title: Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial.
abstract: OBJECTIVE
  To evaluate the microbiological cure rate after treatment with tetracyclines or azithromycin in patients infected with M genitalium.
  
  
  METHODS
  One hundred and fifty-two men and 60 women positive for M genitalium were recruited. Patients treated either with doxycyline for 9 days or with azithromycin 1 g stat. were compared. Those still positive for M genitalium after primary doxycycline treatment received an extended course of azithromycin 500 mg on day 1 followed by 250 mg daily for the following 4 days, whereas those with treatment failure after azithromycin received doxycycline 100 mg twice daily for 15 days.
  
  
  RESULTS
  The eradication rate after azithromycin 1 g stat. was 85% (95% CI 69 to 94) in men (n = 39) and 88% (95% CI 64 to 99) in women (n = 17) and after doxycycline 17% (95% CI 9 to 27) in men (n = 76) and 37% (95% CI 19 to 58) in women (n = 27). Extended azithromycin eradicated M genitalium from 96% (95% CI 85 to 99) of the men (n = 47) and from all six women who failed on doxycycline. Extended doxycycline treatment was insufficient. Persistent urethral inflammation was seen in a substantial portion of the men after eradication of M genitalium regardless of the antibiotic drug, indicating a poor predictive value of urethral smears in evaluation of persistent or recurrent infection.
  
  
  CONCLUSIONS
  Azithromycin was more effective than doxycycline in treating patients infected with M genitalium. The extended course of azithromycin was highly effective but was given after the initial treatment with doxycycline. Randomised clinical trials are needed to compare the different dosages of azithromycin.
authors.affiliation: Karolinska University Hospital, Huddinge, S-141 86 Stockholm, Sweden. eva.bjornelius@karolinska.se
authors.forename: E
authors.initials: E
authors.lastname: Björnelius
authors.forename: C
authors.initials: C
authors.lastname: Anagrius
authors.forename: G
authors.initials: G
authors.lastname: Bojs
authors.forename: H
authors.initials: H
authors.lastname: Carlberg
authors.forename: G
authors.initials: G
authors.lastname: Johannisson
authors.forename: E
authors.initials: E
authors.lastname: Johansson
authors.forename: H
authors.initials: H
authors.lastname: Moi
authors.forename: J S
authors.initials: JS
authors.lastname: Jensen
authors.forename: P
authors.initials: P
authors.lastname: Lidbrink
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017963:Azithromycin / Q000008:administration & dosage*; D004318:Doxycycline / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000188:drug therapy*; D045704:Mycoplasma genitalium; D012537:Scandinavian and Nordic Countries; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin; D004318:Doxycycline